494 related articles for article (PubMed ID: 19842790)
21. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
Fleissig A; Fallowfield LJ; Langridge CI; Johnson L; Newcombe RG; Dixon JM; Kissin M; Mansel RE
Breast Cancer Res Treat; 2006 Feb; 95(3):279-93. PubMed ID: 16163445
[TBL] [Abstract][Full Text] [Related]
22. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
[TBL] [Abstract][Full Text] [Related]
23. The relationship between morbidity after axillary surgery and long-term quality of life in breast cancer patients: the role of anxiety.
Aerts PD; De Vries J; Van der Steeg AF; Roukema JA
Eur J Surg Oncol; 2011 Apr; 37(4):344-9. PubMed ID: 21296542
[TBL] [Abstract][Full Text] [Related]
24. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
Barranger E; Dubernard G; Fleurence J; Antoine M; Darai E; Uzan S
J Surg Oncol; 2005 Oct; 92(1):17-22. PubMed ID: 16180226
[TBL] [Abstract][Full Text] [Related]
25. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
Purushotham AD; Upponi S; Klevesath MB; Bobrow L; Millar K; Myles JP; Duffy SW
J Clin Oncol; 2005 Jul; 23(19):4312-21. PubMed ID: 15994144
[TBL] [Abstract][Full Text] [Related]
26. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
27. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
28. Shoulder morbidity after treatment for breast cancer is bilateral and greater after mastectomy.
Shamley D; Lascurain-Aguirrebeña I; Oskrochi R; Srinaganathan R
Acta Oncol; 2012 Nov; 51(8):1045-53. PubMed ID: 22731831
[TBL] [Abstract][Full Text] [Related]
29. Predictors of arm morbidity following breast cancer surgery.
Hack TF; Kwan WB; Thomas-Maclean RL; Towers A; Miedema B; Tilley A; Chateau D
Psychooncology; 2010 Nov; 19(11):1205-12. PubMed ID: 20099254
[TBL] [Abstract][Full Text] [Related]
30. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery.
Rietman JS; Dijkstra PU; Debreczeni R; Geertzen JH; Robinson DP; De Vries J
Disabil Rehabil; 2004 Jan; 26(2):78-84. PubMed ID: 14668143
[TBL] [Abstract][Full Text] [Related]
31. Arm morbidity and disability after breast cancer: new directions for care.
Thomas-Maclean RL; Hack T; Kwan W; Towers A; Miedema B; Tilley A
Oncol Nurs Forum; 2008 Jan; 35(1):65-71. PubMed ID: 18192154
[TBL] [Abstract][Full Text] [Related]
32. Lymphedema following axillary lymph node dissection for breast cancer.
Sakorafas GH; Peros G; Cataliotti L; Vlastos G
Surg Oncol; 2006 Nov; 15(3):153-65. PubMed ID: 17187979
[TBL] [Abstract][Full Text] [Related]
33. Quality of life and lymphedema following breast cancer.
Heiney SP; McWayne J; Cunningham JE; Hazlett LJ; Parrish RS; Bryant LH; Vitoc C; Jansen K
Lymphology; 2007 Dec; 40(4):177-84. PubMed ID: 18365532
[TBL] [Abstract][Full Text] [Related]
34. Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit.
Bani HA; Fasching PA; Lux MM; Rauh C; Willner M; Eder I; Loehberg C; Schrauder M; Beckmann MW; Bani MR
Patient Educ Couns; 2007 Jun; 66(3):311-8. PubMed ID: 17331692
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of the morbidity of axillary clearance for breast cancer.
Duff M; Hill AD; McGreal G; Walsh S; McDermott EW; O'Higgins NJ
Br J Surg; 2001 Jan; 88(1):114-7. PubMed ID: 11136322
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors for lymphedema of the arm after mastectomy for breast cancer].
Kasse AA; Diop M; Dieng M; Deme A; Ndaw D; Fall MG; Diop PS; Betel E; Dembele B; Drabo B; Timbely G; Toure P
Dakar Med; 1999; 44(1):32-5. PubMed ID: 10797983
[TBL] [Abstract][Full Text] [Related]
37. Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit.
Chetty U; Jack W; Prescott RJ; Tyler C; Rodger A
Br J Surg; 2000 Feb; 87(2):163-9. PubMed ID: 10671921
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study.
Yang EJ; Park WB; Seo KS; Kim SW; Heo CY; Lim JY
J Surg Oncol; 2010 Jan; 101(1):84-91. PubMed ID: 19924721
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study.
Kilgour RD; Jones DH; Keyserlingk JR
Breast Cancer Res Treat; 2008 May; 109(2):285-95. PubMed ID: 17624606
[TBL] [Abstract][Full Text] [Related]
40. Lymphedema and quality of life in Chinese women after treatment for breast cancer.
Mak SS; Mo KF; Suen JJ; Chan SL; Ma WL; Yeo W
Eur J Oncol Nurs; 2009 Apr; 13(2):110-5. PubMed ID: 19246241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
